A novel 1,2,4-triazole derivative inhibits epithelial-mesenchymal transition in metastatic colorectal cancer via β-catenin suppression.

1,2,4-Triazole derivatives have emerged as a significant class of compounds with diverse biological activities, notably their anticancer properties. This therapeutic utility lies in their molecular flexibility and their capacity to interact with key…

Preview only. Read the full abstract at the source